SCINAI IMMUNOTHERAPEUTICS LTD. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.80 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2023-04-17
- SCINAI IMMUNOTHERAPEUTICS LTD. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.80K shares, a 29.37% decline from fiscal 2021.
- SCINAI IMMUNOTHERAPEUTICS LTD. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 8.21K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|
| 2022-12-31 | 5.80K shares 10-K · filed 2023-04-17 |
| 2021-12-31 | 8.21K shares 10-K · filed 2023-04-17 |